CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-26 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −368 | $111.09 | $41K | 69,977 |
| 2020-02-26 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −777 | $112.90 | $88K | 69,200 |
| 2020-02-26 | Davis J. E. EVP, General Diagnostics | Sale | −510 | $111.09 | $57K | 40,392 |
| 2020-02-26 | Davis J. E. EVP, General Diagnostics | Shares withheld for taxes | −1,187 | $112.90 | $134K | 39,205 |
| 2020-02-26 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −1,195 | $112.90 | $135K | 69,756 |
| 2020-02-26 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −4,299 | $112.90 | $485K | 226,560 |
| 2020-02-26 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −773 | $112.90 | $87K | 24,889 |
| 2020-02-26 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −98 | $112.90 | $11K | 24,416 |
| 2020-02-25 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −49 | $113.34 | $6K | 24,514 |
| 2020-02-25 | Davis J. E. EVP, General Diagnostics | Sale | −598 | $112.73 | $67K | 41,454 |
| 2020-02-25 | Davis J. E. EVP, General Diagnostics | Shares withheld for taxes | −552 | $113.34 | $63K | 40,902 |
| 2020-02-25 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −307 | $113.34 | $35K | 41,766 |
| 2020-02-25 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −423 | $113.34 | $48K | 25,662 |
| 2020-02-25 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −2,074 | $113.34 | $235K | 230,859 |
| 2020-02-25 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −405 | $112.73 | $46K | 70,701 |
| 2020-02-25 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −356 | $113.34 | $40K | 70,345 |
| 2020-02-25 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −565 | $113.34 | $64K | 70,951 |
| 2020-02-24 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −56 | $112.17 | $6K | 24,563 |
| 2020-02-24 | Davis J. E. EVP, General Diagnostics | Shares withheld for taxes | −643 | $112.17 | $72K | 42,052 |
| 2020-02-24 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −382 | $112.17 | $43K | 42,073 |
Page 44 of 52 · 1,040 trades